ConductScience.org, home

Paper11250737

Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.

Clare SE and 2 others. Breast Cancer Res, 2000. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer. Papers, record 11250737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11250737

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.
PubMed
Journal
Breast Cancer Res
PubMed
Year
2000
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2019-11-04
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clare SES E
2Nakhlis FF
3Panetta JCJ C

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
Models, BiologicalMajor topic
Neoplasm MetastasisMajor topic
Algorithms
Angiogenesis Inhibitors
Cell Division
Chemotherapy, Adjuvant
Clinical Trials as Topic
Combined Modality Therapy
Disease Progression
Drug Administration Schedule
Drug Resistance, Neoplasm
Female
Humans
Mastectomy
Neoplasm Recurrence, Local
Neovascularization, Pathologic
Reproducibility of Results
Stochastic Processes
Time Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in11250732Molecular biology of breast cancer metastasis. 'Has it spread?': disarming one of the most terrifying questions.https://conductscience.org/library/papers/11250732

Source PubMed

Download CSV of comments and corrections

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18443754Mammographic assessment of human breast cancer growth and duration.Cancer1993https://conductscience.org/library/papers/8443754PubMed
27060033Rationale for the use of alternating non-cross-resistant chemotherapy.Cancer Treat Rep1982https://conductscience.org/library/papers/7060033PubMed
39890174Dormancy of mammary carcinoma after mastectomy.J Natl Cancer Inst1999https://conductscience.org/library/papers/9890174PubMed
410200775Cancer statistics, 1999.CA Cancer J Clin1999https://conductscience.org/library/papers/10200775PubMed
58105098Report of the International Workshop on Screening for Breast Cancer.J Natl Cancer Inst1993https://conductscience.org/library/papers/8105098PubMed
61004590Predicting the course of Gompertzian growth.Nature1976https://conductscience.org/library/papers/1004590PubMed
71960555Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.J Clin Oncol1991https://conductscience.org/library/papers/1960555PubMed
83191483A Gompertzian model of human breast cancer growth.Cancer Res1988https://conductscience.org/library/papers/3191483PubMed
93510732The Norton-Simon hypothesis revisited.Cancer Treat Rep1986https://conductscience.org/library/papers/3510732PubMed
107585012Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.Nat Med1995https://conductscience.org/library/papers/7585012PubMed
117584949Angiogenesis in cancer, vascular, rheumatoid and other disease.Nat Med1995https://conductscience.org/library/papers/7584949PubMed
129342444Computer simulation of a breast cancer metastasis model.Breast Cancer Res Treat1997https://conductscience.org/library/papers/9342444PubMed
133828557On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).Bull Math Biol1986https://conductscience.org/library/papers/3828557PubMed
1449738The curability of breast cancer.Lancet1975https://conductscience.org/library/papers/49738PubMed
152259298Is Gompertzian or exponential kinetics a valid description of individual human cancer growth?Med Hypotheses1990https://conductscience.org/library/papers/2259298PubMed
166744323A stochastic numerical model of breast cancer growth that simulates clinical data.Cancer Res1984https://conductscience.org/library/papers/6744323PubMed
178656257Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients.J Clin Oncol1996https://conductscience.org/library/papers/8656257PubMed
181345869
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.
Lancet1992https://conductscience.org/library/papers/1345869PubMed
198443753Decelerating growth and human breast cancer.Cancer1993https://conductscience.org/library/papers/8443753PubMed
20526911A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.Cancer Treat Rep1979https://conductscience.org/library/papers/526911PubMed

See all 40 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
35487718
Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study.
BMJ Open2022https://conductscience.org/library/papers/35487718PubMed
35103530Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening data.Stat Methods Med Res2022https://conductscience.org/library/papers/35103530PubMed
32825078A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/32825078PubMed
29979733Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).PLoS One2018https://conductscience.org/library/papers/29979733PubMed
28406985Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.PLoS One2017https://conductscience.org/library/papers/28406985PubMed
25588472Modeling drug resistance in a conjoint normal-tumor setting.Theor Biol Med Model2015https://conductscience.org/library/papers/25588472PubMed
24491979Simplifying the complexity of resistance heterogeneity in metastasis.Trends Mol Med2014https://conductscience.org/library/papers/24491979PubMed
22387162The dynamics of drug resistance: a mathematical perspective.Drug Resist Updat2012https://conductscience.org/library/papers/22387162PubMed
21714780Bayesian enrichment strategies for randomized discontinuation trials.Biometrics2012https://conductscience.org/library/papers/21714780PubMed
21194536Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis.J Theor Biol2011https://conductscience.org/library/papers/21194536PubMed
20205682Perspectives on tissue interactions in development and disease.Curr Mol Med2010https://conductscience.org/library/papers/20205682PubMed
19825370Mathematical modeling as a tool for planning anticancer therapy.Eur J Pharmacol2009https://conductscience.org/library/papers/19825370PubMed
15650642Modeling the effect of tumor size in early breast cancer.Ann Surg2005https://conductscience.org/library/papers/15650642PubMed
15642181Recent translational research: computational studies of breast cancer.Breast Cancer Res2005https://conductscience.org/library/papers/15642181PubMed
12479592Treatment of breast cancer with chemotherapy in combination with filgrastim: approaches to improving therapeutic outcome.Drugs2002https://conductscience.org/library/papers/12479592PubMed
11250732Molecular biology of breast cancer metastasis. 'Has it spread?': disarming one of the most terrifying questions.Breast Cancer Res2000https://conductscience.org/library/papers/11250732PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11250737

GET https://conductscience.org/api/papers/v1/11250737/references?page=2